The deubiquitinase USP17LA negatively regulates T-cell activation and attenuates anti-tumor immunity
USP17LA loss enhances T-cell function and anti-tumor activity in murine tumor models. Usp17la-deficient T cells exhibit ...
The ‘Gasoline’ artist is an open book when it comes to their health journey. Learn all about the various illnesses and health setbacks that Halsey has managed here.
Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy in oncology and inflammation and immunology (I&I), will present a ...
Made Scientific, a leading cell therapy contract development and manufacturing organization (CDMO) and Syenex, a synthetic biology company specializing in best-in-class targeted delivery technologies, ...
Scientists discovered that inhibiting the enzyme STK17B forces multiple myeloma cells into iron-driven death and makes ...
In experiments with mouse models of breast, pancreatic, and muscle cancers, researchers at Johns Hopkins All Children's Hospital report new evidence that a novel means of boosting the natural immune ...
High IL1RAP protein expression on tumor cells is linked to poor survival in PDAC patients treated with chemotherapy, while this patient group has the longest survival when treated with nadunolimab in ...
Post-CAR T infection prophylaxis should follow European Hematology Association/European Society for Blood and Marrow ...
Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma cancer cells, but also ...
DelveInsight's TL1A Binder Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...
Watch the 'What This Means' video hereFeaturing Company’s second-generation T-Cell Engager program and advantages over first-generationCompany’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results